Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM1 | P11229 | 2/20 | 0.31 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.31 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.31 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.31 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphonic Acid SCHEMBL10492750 | 0.83 | — | — | |
| N,N-Dimethylethanaminium SCHEMBL9435733 | 0.82 | — | — | |
| Phosphonic Acid SCHEMBL6062761 | 0.79 | CHRM2 (0.33) | CHRM1CHRM2CHRM4CHRM5CHRM3 | |
| Phosphonic Acid SCHEMBL6418796 | 0.79 | CHRM2 (0.33) | CHRM1CHRM2CHRM4CHRM5CHRM3 | |
| Phosphonic Acid SCHEMBL11673943 | 0.79 | CA12 (0.47) | CHRM1CHRM2CHRM4CHRM5CHRM3 | |
| Phosphonic Acid SCHEMBL28512514 | 0.78 | DNM1 (0.39) | CHRM1CHRM2CHRM4CHRM5CHRM3 | |
| Phosphonic Acid SCHEMBL3793734 | 0.76 | ALDH1A1 (0.33) | — | |
| Trimethylammonium SCHEMBL869014 | 0.76 | ALDH1A1 (0.36) | — | |
| Phosphonic Acid SCHEMBL8445453 | 0.76 | ALDH1A1 (0.33) | — | |
| Trimethylammonium SCHEMBL5834288 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0586521-A1 | CALCIUM, TRACE MINERAL, VITAMIN D AND DRUG THERAPY COMBINATIONS | THE PROCTER & GAMBLE COMPANY (US) | 1994-03-16 | — | — | EP | disclosed |
| WO-1992021355-A1 | CALCIUM, TRACE MINERAL, VITAMIN D AND DRUG THERAPY COMBINATIONS | THE PROCTER & GAMBLE COMPANY (US) | 1992-12-10 | — | — | WO | disclosed |
| EP-0351897-A2 | Skin penetration system for salts of amine-functional drugs | THE PROCTER & GAMBLE COMPANY (US) | 1990-01-24 | — | — | EP | disclosed |